Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Effect of Suppressive Oligodeoxynucleotides on the Development of Inflammation-Induced Papillomas
  2. Ikeuchi, H.; Kinjo, T.; Klinman, D. M.
  3. Cancer Prevention Research. 2011, May; 4(5): 752-757.
  1. 2.   Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologists
  2. Schonfeld, S. J.; Bhatti, P.; Brown, E. E.; Linet, M. S.; Simon, S. L.; Weinstock, R. M.; Hutchinson, A. A.; Stovall, M.; Preston, D. L.; Alexander, B. H.; Doody, M. M.; Sigurdson, A. J.
  3. Cancer Causes & Control. 2010, Nov; 21(11): 1857-1866.
  1. 3.   Inhibition of Hypoxia Inducible Factor-1 alpha by Dihydroxyphenylethanol, a Product from Olive Oil, Blocks Microsomal Prostaglandin-E Synthase-1/Vascular Endothelial Growth Factor Expression and Reduces Tumor Angiogenesis
  2. Terzuoli, E.; Donnini, S.; Giachetti, A.; Iniguez, M. A.; Fresno, M.; Melillo, G.; Ziche, M.
  3. Clinical Cancer Research. 2010, Aug; 16(16): 4207-4216.
  1. 4.   Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells
  2. Moody, T. W.; Switzer, C.; Santana-Flores, W.; Ridnour, L. A.; Berna, M.; Thill, M.; Jensen, R. T.; Sparatore, A.; Del Soldato, P.; Yeh, G. C.; Roberts, D. D.; Giaccone, G.; Wink, D. A.
  3. Lung Cancer. 2010, May; 68(2): 154-160.
  1. 5.   PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)
  2. Dossus, L.; Kaaks, R.; Canzian, F.; Albanes, D.; Berndt, S. I.; Boeing, H.; Buring, J.; Chanock, S. J.; Clavel-Chapelon, F.; Feigelson, H. S.; Gaziano, J. M.; Giovannucci, E.; Gonzalez, C.; Haiman, C. A.; Hallmans, G.; Hankinson, S. E.; Hayes, R. B.; Henderson, B. E.; Hoover, R. N.; Hunter, D. J.; Khaw, K. T.; Kolonel, L. N.; Kraft, P.; Ma, J.; Le Marchand, L.; Lund, E.; Peeters, P. H. M.; Stampfer, M.; Stram, D. O.; Thomas, G.; Thun, M. J.; Tjonnel, A.; Trichopoulos, D.; Tumino, R.; Riboli, E.; Virtamo, J.; Weinstein, S. J.; Yeager, M.; Ziegler, R. G.; Cox, D. G.
  3. Carcinogenesis. 2010, Mar; 31(3): 455-461.
  1. 6.   Urothelial Overexpression of Insulin-Like Growth Factor-1 Increases Susceptibility to p-Cresidine-Induced Bladder Carcinogenesis in Transgenic Mice
  2. Hursting, S. D.; Perkins, S. N.; Lavigne, J. A.; Beltran, L.; Haines, D. C.; Hill, H. L.; Alvord, W. G.; Barrett, J. C.; DiGiovanni, J.
  3. Molecular Carcinogenesis. 2009 48(8): 671-677.
  1. 7.   Proline oxidase, a p53-induced gene, targets COX-2/PGE(2) signaling to induce apoptosis and inhibit tumor growth in colorectal cancers
  2. Liu, Y.; Borchert, G. L.; Surazynski, A.; Phang, J. M.
  3. Oncogene. 2008 27(53): 6729-6737.
  1. 8.   Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer
  2. Daugherty, S. E.; Shugart, Y. Y.; Platz, E. A.; Fallin, M. D.; Isaacs, W. B.; Pfeiffer, R. M.; Welch, R.; Huang, W. Y.; Reding, D.; Hayes, R. B.
  3. Prostate. 2007, Oct; 67(14): 1487-1497.
  1. 9.   Precancer in mice: Animal models used to understand, prevent, and treat human precancers
  2. Cardiff, R. D.; Anver, M. R.; Boivin, G. P.; Bosenberg, M. W.; Maronpot, R. R.; Molinolo, A. A.; Nikitin, A. Y.; Rehg, J. E.; Thomas, G. V.; Russell, R. G.; Ward, J. M.
  3. Toxicologic Pathology. 2006 34(6): 699-707.
  1. 10.   Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
  2. Ali, I. U.; Luke, B. T.; Dean, M.; Greenwald, P.
  3. British Journal of Cancer. 2005, OCT 17; 93(8): 953-959.
  1. 11.   Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex
  2. Youn, H. S.; Lee, J. Y.; Fitzgerald, K. A.; Young, H. A.; Akira, S.; Hwang, D. H.
  3. Journal of Immunology. 2005, SEP 1; 175(5): 3339-3346.
  1. 12.   Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE(2) and TGF-beta(1)
  2. Ha, C. T.; Waterhouse, R.; Wessells, J.; Wu, J. A.; Dveksler, G. S.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 948-957.
  1. 13.   The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours
  2. Youngren, K. K.; Coveney, D.; Peng, X. N.; Bhattacharya, C.; Schmidt, L. S.; Nickerson, M. L.; Lamb, B. T.; Deng, J. M.; Behringer, R. R.; Capel, B.; Rubin, E. M.; Nadeau, J. H.; Matin, A.
  3. Nature. 2005, MAY 19; 435(7040): 360-364.
  1. 14.   Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype
  2. Kowara, R.; Karaczyn, A.; Cheng, R. Y. S.; Salnikow, K.; Kasprzak, K. S.
  3. Toxicology and Applied Pharmacology. 2005, MAY 15; 205(1): 1-10.
  1. 15.   Reactive oxygen species and lung tumorigenesis by mutant K-ras: A working hypothesis
  2. Maciag, A.; Anderson, L. M.
  3. Experimental Lung Research. 2005, JAN-FEB; 31(1): 83-104.
  1. 16.   Mutant K-ras(V12) increases COX-2, peroxides and DNA damage in lung cells
  2. Maciag, A.; Sithanandam, G.; Anderson, L. M.
  3. Carcinogenesis. 2004, NOV; 25(11): 2231-2237.
  1. 17.   5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking
  2. Catalano, A.; Caprari, P.; Soddu, S.; Procopio, A.; Romano, M.
  3. Faseb Journal. 2004, SEP; 18(12): Published online only.
  1. 18.   Micro-MRI methods to detect renal cysts in mice
  2. Kobayashi, H.; Kawamoto, S.; Brechbiel, M. W.; Jo, S. K.; Hu, X. Z.; Yang, T. X.; Diwan, B. A.; Waldmann, T. A.; Schnermann, J.; Choyke, P. L.; Star, R. A.
  3. Kidney International. 2004 65(4): 1511-1516.
  1. 19.   Polyoma enhancer activator 3, an Ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells
  2. Liu, Y. M.; Borchert, G. L.; Phang, J. M.
  3. Journal of Biological Chemistry. 2004 279(18): 18694-18700.
  1. 20.   Serum proteomic profiles suggest celecoxib-modulated targets and response predictors
  2. Zhen, X. A.; Luke, B. T.; Izmirlian, G.; Umar, A.; Lynch, P. M.; Phillips, R. K. S.; Patterson, S.; Conrads, T. P.; Veenstra, T. D.; Greenwald, P.; Hawk, E. T.; Ali, L. U.
  3. Cancer Research. 2004 64(8): 2904-2909.
  1. 21.   Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
  2. Hingorani, S. R.; Petricoin, E. F.; Maitra, A.; Rajapakse, V.; King, C.; Jacobetz, M. A.; Ross, S.; Conrads, T. P.; Veenstra, T. D.; Hitt, B. A.; Kawaguchi, Y.; Johann, D.; Liotta, L. A.; Crawford, H. C.; Putt, M. E.; Jacks, T.; Wright, C. V. E.; Hruban, R. H.; Lowy, A. M.; Tuveson, D. A.
  3. Cancer Cell. 2003 4(6): 437-450.
  1. 22.   Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography
  2. Castle, P. E.; Phillips, T. M.; Hildesheim, A.; Herrero, R.; Bratti, M. C.; Rodriguez, A. C.; Morera, L. A.; Pfeiffer, R.; Hutchinson, M. L.; Pinto, L. A.; Schiffman, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2003 12(12): 1449-1456.
  1. 23.   Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; Is chemoprevention against multidrug resistance possible?
  2. Ratnasinghe, D.; Daschner, P. J.; Anver, M. R.; Kasprzak, B. H.; Taylor, P. R.; Yeh, G. C.; Tangrea, J. A.
  3. Anticancer Research. 2001 21(3C): 2141-2147.
  1. 24.   Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells
  2. Mei, J. M.; Hord, N. G.; Winterstein, D. F.; Donald, S. P.; Phang, J. M.
  3. Faseb Journal. 2000 14(9): 1188-1201.
  1. 25.   Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated beta-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc
  2. Mei, J. M.; Hord, N. G.; Winterstein, D. F.; Donald, S. P.; Phang, J. M.
  3. Carcinogenesis. 1999 20(4): 737-740.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel